[Skip to the briefing](/briefings/follow-up-brief/#main)

[Care, considered.](/)

Plain-language guide

Care briefing

# The visit ends. The questions may not.

Ask how the plan will be reviewed before leaving the first visit. A prescription can be part of the plan; it does not explain how ongoing care will work.

FDA is short for Food and Drug Administration, the US agency that reviews medicines.

[Browse the briefings](/briefings/at-a-glance/)

![A ceramic arch and a clear glass plane resting apart on black cloth.](/assets/media/routes.webp)

Know how to contact the person reviewing your care.

Source-linked

## Starting care and reviewing it

[Read sources](/briefings/follow-up-brief/#source-file)

The goal

#### First conversation

Write down what the plan is meant to address and what the clinician needs to learn next.

#### Later conversation

Bring back what has changed, what has not and what you still do not understand.

New information

#### First conversation

Ask where to send a test result or a detail you forgot to mention.

#### Later conversation

Ask who reviews that information and whether it changes the next step.

Contact

#### First conversation

Get contact details for questions about your health or medicine, as well as for questions about bills or deliveries.

#### Later conversation

Ask how the clinician can be reached and what to do if the usual contact route is unavailable.

A usable plan includes who reviews new information and how a question gets an answer.

## An online plan can include care in person

The doctor-licensing boards’ group advises sending patients for an in-person visit when an online health check needs an exam or test that cannot happen online.

Ask who arranges the in-person visit or test, and how the results get back to the clinician. Keep a copy of the plan and medicine name together.

## Ask who is available after medicine arrives

As of September 2026, the FDA flags weight-medicine services where patients cannot reach a licensed doctor with questions after delivery.

Ask how to reach the pharmacist about the medicine and the prescriber about changes in your health. Get phone numbers or message addresses and expected reply times.

## Leave with a plan you can repeat back

### What happens next?

Ask what the next review needs to cover and how it is arranged.

### What would make the plan change?

Ask what information would lead the clinician to reconsider the proposed care.

### What still needs an answer?

Keep any open question in the written plan so it is not lost between visits.

Sources for this briefing

Choose the source for your question. For a doctor’s licence, use the state licence search. For a medicine’s approval, ask to see the FDA approval and approved label for that exact product.

Group of doctor-licensing offices · Assessment and referral

The guidance describes responsibilities when remote care needs further testing or an exam.

[Read the source](https://www.fsmb.org/siteassets/advocacy/policies/fsmb-workgroup-on-telemedicineapril-2022-final.pdf)

FDA · Access after delivery

The FDA’s consumer checks include whether patients can reach a licensed doctor with questions once the medicine arrives.

[Read the source](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss)

Continue with a related question

[Bring questions that need real answers.](/briefings/question-brief/)

Use these pages to compare peptide care; this is a guide and no treatment is prescribed or sold here.

[All briefings](/briefings/at-a-glance/)

[Questions to bring](/briefings/question-brief/)

[Source records](/briefings/follow-up-brief/#source-file)

[Text copy](/briefings/follow-up-brief/index.md)

[Start](/)

[Care](/briefings/care-routes/)

[Costs](/briefings/cost-brief/)

[Checks](/briefings/licence-brief/)

[Briefings](/briefings/at-a-glance/)